Dosing is Complete in Lexaria's Second GLP-1 Human Pilot Study

Go back to Dosing is Complete in Lexaria's Second GLP-1 Human Pilot Study
(NASDAQ: LEXX) Delayed: 3.22 +0.30 (10.27%)
Previous Close $2.92    52 Week High $ 
Open $2.91    52 Week Low $ 
Day High $3.31    P/E N/A 
Day Low $2.91    EPS $ 
Volume 43,069